TESTOSTERONE ENANTHATE INJECTION, USP SOLUTION

Страна: Канада

Язык: английский

Источник: Health Canada

Активный ингредиент:

TESTOSTERONE ENANTHATE

Доступна с:

HIKMA CANADA LIMITED

код АТС:

G03BA03

ИНН (Международная Имя):

TESTOSTERONE

дозировка:

200MG

Фармацевтическая форма:

SOLUTION

состав:

TESTOSTERONE ENANTHATE 200MG

Администрация маршрут:

INTRAMUSCULAR

Штук в упаковке:

15G/50G

Тип рецепта:

Schedule G (CDSA IV)

Обзор продуктов:

Active ingredient group (AIG) number: 0106403001; AHFS:

Статус Авторизация:

APPROVED

Дата Авторизация:

2023-03-17

Характеристики продукта

_Testosterone Enanthate Injection, USP _
_Page 1 of 17 _
PRESCRIBING INFORMATION
TESTOSTERONE ENANTHATE INJECTION, USP
Solution for Injection,
200 mg / mL
Androgens
Hikma Canada Limited
5995 Avebury Road, Suite 804
Mississauga, ON
L5R 3P9, Canada
Date of Preparation:
March 17, 2023
Submission Control No: 264978
C
_Testosterone Enanthate Injection, USP _
_Page 2 of 17 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
................................................................. 3
SUMMARY PRODUCT INFORMATION
..............................................................................
3
INDICATIONS AND CLINICAL USE
.....................................................................................
3
CONTRAINDICATIONS
......................................................................................................
3
WARNINGS AND PRECAUTIONS
.......................................................................................
4
ADVERSE
REACTIONS
........................................................................................................
7
DOSAGE AND ADMINISTRATION
...................................................................................
10
ACTION AND CLINICAL PHARMACOLOGY
......................................................................
11
STORAGE AND STABILITY
...............................................................................................
13
DOSAGE FORMS, COMPOSITION AND PACKAGING
....................................................... 13
PART II: SCIENTIFIC INFORMATION
..................................................................................
14
PHARMACEUTICAL
INFORMATION
................................................................................
14
CLINICAL TRIALS
.............................................................................................................
14
PART III: CONSUMER
INFORMATION................................................................................
16
_Testosterone Enanthate Injection, USP _
_Page 3